NCT01629446View on ClinicalTrials.gov

Lofexidine Mass Balance in Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Normal Healthy Volunteers
Interventions
DRUG

Lofexidine hydrochloride

Single Dose = Solution containing 400 μg lofexidine HCl and a tracer amount of 14C lofexidine

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

USWM, LLC (dba US WorldMeds)

INDUSTRY

NCT01629446 - Lofexidine Mass Balance in Volunteers | Biotech Hunter | Biotech Hunter